David Magnus, Ph.D., the Thomas A. Raffin Professor in Medicine and Biomedical Ethics, is Director of the Center and co-Chair of the Ethics Committee for the Stanford Health Center. He is also Director of the Scholarly Concentration in Biomedical Ethics and Medical Humanities in the School of Medicine.
Mildred Cho, Ph.D., Associate Director of the Center is also Professor of Pediatrics. Her major areas of interest are the ethical and social issues raised by new technologies such as genetic testing, gene therapy, pharmacogenetics, and gene patents. She also studies how academic-industry ties affect the conduct of biomedical research.
Henry Greely, J.D., Chair of SCBE's Steering Committee, is Professor of Law and Professor, by courtesy, of Genetics at Stanford University. Specializing in health law and policy, Greely has written on cloning, the implications of genetics for the health care system, health care insurance and financing and the stem cell debate.
Thomas A. Raffin, M.D., Co-Founder and Director Emeritus of the Center, is Colleen and Robert Haas Professor Emeritus of Medicine and Bioethics and former Chief of the Division of Pulmonary and Critical Care Medicine. In addition to biomedical ethics (withholding and withdrawing life support, medical decision-making in the context of managed care and HMOs, ethics of neurosciences, and ethical issues in human genetics), Dr. Raffin's other key areas of academic interest include the biology of acute lung injury, pulmonary fibrosis, and lymphangioleiomyomatosis.
Holly Tabor, Ph.D., Associate Professor of Medicine and the Associate Director for Clinical Ethics and Education. She is returning to SCBE after eight years at the Treuman Katz Center for Pediatric Bioethics at Seattle Children’s Research Institute and at the University of Washington. She received her PhD in Epidemiology from Stanford in 2002, and then was a Senior Scientist at the Stanford Human Genome Center. From 2005-2008 she was one of the first postdoctoral fellows at CIRGE/SCBE. Her research focuses on ethical issues in genetics and genomics, specifically return of results and translation for exome and whole genome sequencing.